Free Trial

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Ryan Specialty logo with Finance background

Connor Clark & Lunn Investment Management Ltd. trimmed its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 31.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,713 shares of the company's stock after selling 12,067 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in Ryan Specialty were worth $1,707,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in RYAN. Hollencrest Capital Management bought a new position in Ryan Specialty in the third quarter valued at approximately $25,000. Assetmark Inc. bought a new position in Ryan Specialty in the third quarter valued at about $34,000. GAMMA Investing LLC raised its stake in Ryan Specialty by 96.4% during the second quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after acquiring an additional 297 shares in the last quarter. Crewe Advisors LLC bought a new position in shares of Ryan Specialty in the second quarter worth about $39,000. Finally, Signaturefd LLC boosted its stake in shares of Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after purchasing an additional 148 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 5,375 shares of the firm's stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total transaction of $347,923.75. Following the completion of the transaction, the director now owns 2,685 shares of the company's stock, valued at approximately $173,800.05. This trade represents a 66.69 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares in the company, valued at approximately $884,236.54. This represents a 54.42 % decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Trading Up 0.7 %

Shares of Ryan Specialty stock traded up $0.51 during trading on Tuesday, hitting $75.10. The stock had a trading volume of 1,090,854 shares, compared to its average volume of 871,530. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm's fifty day simple moving average is $69.27 and its 200-day simple moving average is $62.80. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.50. The stock has a market cap of $19.66 billion, a PE ratio of 97.49, a PEG ratio of 1.67 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the previous year, the business posted $0.32 EPS. Ryan Specialty's revenue was up 20.5% on a year-over-year basis. As a group, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be given a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.59%. Ryan Specialty's payout ratio is presently 57.14%.

Analyst Ratings Changes

A number of brokerages have recently commented on RYAN. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. UBS Group upped their price target on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research report on Tuesday, August 13th. JPMorgan Chase & Co. lifted their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a report on Friday, August 2nd. The Goldman Sachs Group increased their price objective on Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a report on Wednesday, October 9th. Finally, Bank of America lifted their target price on Ryan Specialty from $75.00 to $84.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $71.67.

View Our Latest Stock Report on RYAN

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Recommended Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

→ Elon Musk’s chilling warning for humanity (From The Freeport Society) (Ad)

Should you invest $1,000 in Ryan Specialty right now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines